NCT06873607Completed
Effectiveness Evaluation of a Mobile Application for Rheumatoid Arthritis
Evaluation of the Effectiveness of a Mobile Application Developed for Individuals With Rheumatoid Arthritis
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
The aim of this experimental study is to develop a mobile application for patients with rheumatoid arthritis based on evidence-based recommendations and to evaluate the effectiveness of the developed application. Research Questions 1. Is the mobile application developed for patients with rheumatoid arthritis effective in improving their quality of life? 2. Is the mobile application developed for patients with rheumatoid arthritis effective in reducing their disease activity? The researchers will enable the intervention group to use the mobile application in order to assess its effectiveness, while the control group will receive routine care throughout the study period. Participants in the intervention group will use the mobile application for 12 weeks. Changes in the parameters determined by the researchers will be examined before and after the usage period. Patients in the control group will be evaluated after the initial consultation and at the end of 12 weeks. At the conclusion of the study, the control group will also be provided access to the mobile application.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 90 (actual)
- First submitted
- 7 Mar 2025
- Start date
- 1 Jul 2025
- Primary completion date
- 31 Jan 2026
- Lead sponsor
- Kırıkkale University
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT06873607
What you commit to
- Study type: Interventional
- Participants enrolled: 90
- From 1 Jul 2025 to the primary completion date, 31 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having a diagnosis of inflammatory diseases or a disease that may significantly affect the functional status (such as Multiple Sclerosis, stroke, Systemic Lupus Erythematosus, Ankylosing Spondylitis, Psoriatic Arthritis)
- Not having any neurological or psychiatric disease/problem diagnosed by a physician
Other
- Pregnancy or breastfeeding
- Wanting to withdraw from the study
- Exiting during the study process
- Not logging in to the mobile application once a week during the study implementation period (twelve weeks) for the intervention group
Who the study is looking for
- Be 18 years of age or older
- Diagnosis of Rheumatoid Arthritis according to the American College of Rheumatology (ACR) 1987 criteria
- Receiving stable treatment for the last 3 months with no new treatments added at the last check-up
- Ability to read and write in Turkish
- Ownership of a personal smartphone with internet connectivity and the ability to use an application
- Willingness to participate in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Health Science Gulhane Training and Research Hospital Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.